Viewing Study NCT05911360


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-01-24 @ 9:55 PM
Study NCT ID: NCT05911360
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-01
First Post: 2023-06-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF
Sponsor: ViiV Healthcare
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Human Immunodeficiency Virus (HIV)-1 View
None Dolutegravir View
None Lamivudine View
None Bictegravir View
None Emtricitabine View
None Tenofovir alafenamide View
None Dovato View
None Biktarvy View
None Switch study View
None ≥ 50 years View